跳至主要内容
临床试验/IRCT2015042521935N1
IRCT2015042521935N1已完成未知

Evaluating the effect of vitamin D3 supplementation on clinical signs, inflammatory and oxidative stress bio-markers in patients with Irritable Bowel Syndrome: A randomized double blinded clinical trial

Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 years 至 60 years(—)
性别
All

入选标准

  • Including criteria: the patients who are 19-60 years old diagnosed with Irritable Bowel Syndrome (IBS) according to ROME III criteria; Signed consent by the patient.
  • Exclusion criteria: The patients who have celiac disease (diagnosed by a duodenal biopsy or celiac serological tests), any other diseases of the gastrointestinal tract such as IBD, any kind of abdominal surgery, chronic disease such as diabetes, cardiovascular, hepatic, kidney and severe infection; Pregnancy; Breastfeeding; Smoking; Alcohol consumption; Use of dietary supplements; Use of vitamin D and calcium supplement during the last year before the study; Use any medication for improvement of disease signs during the study period.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences

相似试验